Topic 19. Drug Allergy

download Topic 19. Drug Allergy

of 3

Transcript of Topic 19. Drug Allergy

  • 7/28/2019 Topic 19. Drug Allergy

    1/3

    Efi. Gelerstein 2011

    Topic 19. Drug allergyAlmost any drug can cause a cutaneous reaction, and many infla. skin conditions can be caused orexacerbated by drugs. A drug reaction can reasonably be included in the DD of most skin diseases.

    Adverse drug reactions

    1) Intolerance pharmacologically predictable, individual susceptibility -pharmacogenetics, e.g.tinnitus due to small amount of aspirin2) Idiosyncratic genetic defect (G6PD def.)

    3) Cumulative effect (amiodaron hyperpigmentation)4) Drug-specific reactions

    Drug allergy: pseudo-allergic reaction True allergic reaction Specificity, immune memory

    Immune-mediated drug allergy

    1) Hapten model Drug binds covalently to proteins APC processing peptide presentation endogen: MHC-I (8-10 amino acid), exogen MHCII (13-23 amino acid)

    2) Direct recognition model Drug binds directly to peptides Processing not required Fixed APC binds SMX and presents it to T cells

    Drugs as antigens

    High MW Complete Ag (insulin, hormones, enzymes, protamine, antise., recombinant proteins) Small MW Functionally complete Ag (Succinylcholine, ammonium) Haptens Small MW, incomplete Ag binds covalently to a larger molecule: multivalent hapten

    carrier complex = complete antigen

    Drug induced hypersensitivity reactions

    Autoimmune diseases (pemphigoid, SLE, lichen, hemolytic anemia) IgE mediated anaphylaxis, urticaria Immune complex vasculitis, fever, serum sickness Contact dermatitis Morbilliform exanthematous reaction, maculopapular reaction Fix drug eruption, erythema multiforme, Steven Johnson sy, Lyell sy. (toxic epidermal necrolysis, TEN

    Stevens Johnsons syndrome:Severe variant of erythema multiforme associated with fever and mucous mem. lesions.

    The oral mucosa, lips and bulbar conjunctivae are most commonly affected Rapidly spreading macules leads to epidermal blistering, necrosis. Triggered by: Sulfa drugs, antiepileptic, antibiotics.

    T cell role

    T memory, B memory - B activation needs T cell help Drug specific Th2 cells - in urticaria, anaphylaxis Drug specific Th1 cells - CD8+ cytotoxic T cells, effector function, toxic for keratinocytes, B cells in

    contact dermatitis, morbilliform exanthema, bullous reactions

  • 7/28/2019 Topic 19. Drug Allergy

    2/3

    Efi. Gelerstein 2011

    Drug reactions

    1) Immediate type 30 min IgE mediated2) Late type 3-8 hours IgE mediated late phase reaction (IL5,eo-s), Arthrus reaction, IC reaction3) Delayed type 24-48 hours contact HS, morbilliform reactions, bullous reactions (EM, SJS, TEN)

    Coombs-Gell classification

    This classification divides drug allergies into 4 pathophysiological types:

    Type I anaphylaxis (IgE) Urticaria Angioedema Anaphylaxis

    Type II Ab mediated cytotoxicity Thrombocytopenic purpuraType III IC mediated reaction Leukocytoclastic vasculitis

    Serum sicknessType IV delayed type HS (cell mediated) Allergic contact dermatitis

    Some exanthems Photoallergic reactions

    Multiple drug allergy syndromes

    Specific disease background1. Sulfonamide - AIDS2. Penicillin - abnormal lymphocytes

    (+) family history1. Penicillin allergy: 10x more likely to develop allergy to

    other antibiotics

    Atopy genetic predisposition toward the development ofimmediate hypersensitivity reactions

    High immunogenicity to drug - hapten complexPseudo-allergic reactions

    Contrast materials shock Aspirin asthma Opiate urticaria Protamine pulmonary hypertension NSAID urticaria Primaquine (malaria) haemolytic anemia G6PD deficiency Local anesthetics syncope Vancomycin flushing INH hepatitis

    Diagnosis of drug allergy

    Case history Histology, immunehistology Stop the drug, treat the symptoms Lymphocyte transformation test, measure spec IgE, basophile degranulation test Provocation (skin tests, oral challenge)

  • 7/28/2019 Topic 19. Drug Allergy

    3/3

    Efi. Gelerstein 2011

    SCORTEN - 7 point

    SCORTEN Scale is a severity-of-illness scale with which the severity of certain bullous conditions can besystematically determined.

    The term "SCORTEN" stands forSCORe ofToxic Epidermal Necrosis

    It was originally developed forToxic Epidermal Necrolysisbut can be used with burn victims, sufferers

    of SJS, cutaneous drug reactions, or exfoliative wounds these conditions have in common that theycompromise the integrity of the skin and/or mucous mem.

    In the SCORTEN Scale 7 independent risk factors for high mortality are systematically scored, so as to

    determine the mortality rate for that particular patient.

    1. Age > 40 years2. Malignant tumour in history3. BSA (body surface area) necrolysis > 10%4. Pulse > 120/min5. serum BUN > 10mmol/L6. HCO3 < 20mmol/L7. Glucose > 14mmol/L

    Some common reaction patterns and drugs which can cause them:

    Toxic (reactive) erythema Antibiotics (esp. Ampicillin) sulphonamides and related compounds (diuretics and

    hypoglycaemics)

    Barbiturates phenylbutazone

    Urticaria salicylates (most common) histamine releasers Antibiotics

    Allergic vasculitis Sulphonamides Phenylbutazone phenytoin oral contraceptives are among the possible causes

    Erythema multiforme Sulphonamides Barbiturates Phenylbutazone.

    Purpura Thiazides Sulphonamides Phenylbutazone Barbiturates Quinine

    Bullous eruptions Bullae may also develop at pressure sites in drug induced comaEczema Penicillin

    Sulphonamides Phenothiazines Local anaesthetics

    SCORTEN of 5 or more > 90% mortality

    http://en.wikipedia.org/wiki/Bulloushttp://en.wikipedia.org/wiki/Toxic_Epidermal_Necrolysishttp://en.wikipedia.org/wiki/Mortality_ratehttp://en.wikipedia.org/wiki/Mortality_ratehttp://en.wikipedia.org/wiki/Toxic_Epidermal_Necrolysishttp://en.wikipedia.org/wiki/Bullous